XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Carrying and Estimated Fair Value of Other Financial Instruments
The following tables present the carrying amounts and estimated fair values of our financial instruments by hierarchy level as of December 31, 2022 and 2021:
December 31, 2022
Hierarchy Level
(Fair Value)
Carrying
Amount
Level 1Level 2Level 3
Liabilities
Acquisition-related contingent consideration (1)
$14,988 $— $— $14,988 
2023 Convertible Notes (2)
315,172 — 509,682 — 
Total$330,160 $— $509,682 $14,988 
December 31, 2021
Hierarchy Level
(Fair Value)
Carrying
Amount
Level 1Level 2Level 3
Liabilities   
Acquisition-related contingent consideration (1)
$15,110 $— $— $15,110 
2023 Convertible Notes (2)
297,158 — 466,619 — 
Total$312,268 $— $466,619 $15,110 
(1)The short-term portion is included in “Accounts payable, accrued expenses and other,” and the long-term portion is included in “Other liabilities” on the Consolidated Balance Sheets.  
(2)The carrying value as of December 31, 2022 includes unamortized deferred debt issuance costs. The carrying value as of December 31, 2021 includes unamortized deferred debt issuance costs and debt discount.
Schedule of Acquisition-Related Contingent Consideration
The change in our liability for acquisition-related contingent consideration for our Level 3 financial instruments is as follows:
Contingent Consideration
Balance at December 31, 2019$14,826 
Additions$3,460 
Accretion expense (1)
5,593 
Payments(4,692)
Foreign currency translation adjustment (2)
931 
Balance at December 31, 2020$20,118 
Additions$1,093 
Accretion expense (1)
2,771 
Remeasurement gain (3)
(3,095)
Payments(5,122)
Foreign currency translation adjustment (2)
(655)
Balance at December 31, 2021$15,110 
Additions (4)
$5,370 
Accretion expense (1)
2,396 
Payments(7,671)
Foreign currency translation adjustment and other (2)
(217)
Balance at December 31, 2022$14,988 
(1)Accretion expense is included in “Selling, general and administrative expenses” on the Consolidated Statements of Comprehensive Income.
(2)Foreign currency translation adjustments are included in “Other comprehensive income (loss), net of tax” on the Consolidated Statements of Comprehensive Income.
(3)Remeasurement gain or loss resulting from a change in fair value of an acquisition's contingent consideration liability is recorded in SG&A expenses on the Consolidated Statements of Comprehensive Income.
(4)During the year ended December 31, 2022, we acquired a business that was assigned to the Corporate Finance segment.